Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.25 USD | -1.15% | +3.73% | +28.54% |
Jun. 06 | HC Wainwright Initiates Lexeo Therapeutics at Buy With $22 Price Target | MT |
May. 09 | Lexeo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 900K | Capitalization | 568M |
---|---|---|---|---|---|
Net income 2024 * | -74M | Net income 2025 * | -86M | EV / Sales 2024 * | - |
Net cash position 2024 * | 225M | Net cash position 2025 * | 120M | EV / Sales 2025 * | 498 x |
P/E ratio 2024 * |
-6.89
x | P/E ratio 2025 * |
-7.05
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.39% |
1 day | -1.15% | ||
1 week | +3.73% | ||
Current month | +3.73% | ||
1 month | +28.44% | ||
3 months | +17.51% | ||
6 months | +32.69% | ||
Current year | +28.54% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 17.25 | -1.15% | 121,030 |
24-06-06 | 17.45 | +1.51% | 346,963 |
24-06-05 | 17.19 | +0.53% | 244,342 |
24-06-04 | 17.1 | +0.29% | 183,464 |
24-06-03 | 17.05 | +2.53% | 219,241 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.54% | 568M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- LXEO Stock